These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 19414940)

  • 61. Frequency and predictors of hyperkalemia in patients ≥60 years of age with heart failure undergoing intense medical therapy.
    Muzzarelli S; Maeder MT; Toggweiler S; Rickli H; Nietlispach F; Julius B; Burkard T; Pfisterer ME; Brunner-La Rocca HP;
    Am J Cardiol; 2012 Mar; 109(5):693-8. PubMed ID: 22152974
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS).
    Pitt B; Bakris G; Ruilope LM; DiCarlo L; Mukherjee R;
    Circulation; 2008 Oct; 118(16):1643-50. PubMed ID: 18824643
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evaluation of an individualized dose titration regimen of patiromer to prevent hyperkalaemia in patients with heart failure and chronic kidney disease.
    Pitt B; Bushinsky DA; Kitzman DW; Ruschitzka F; Metra M; Filippatos G; Rossignol P; Du Mond C; Garza D; Berman L; Lainscak M;
    ESC Heart Fail; 2018 Jun; 5(3):257-266. PubMed ID: 29369537
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of mineralocorticoid receptor antagonist spironolactone on cardiac sympathetic nerve activity and prognosis in patients with chronic heart failure.
    Kasama S; Toyama T; Sumino H; Kumakura H; Takayama Y; Minami K; Ichikawa S; Matsumoto N; Sato Y; Kurabayashi M
    Int J Cardiol; 2013 Jul; 167(1):244-9. PubMed ID: 22245478
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Hyperkalemia in congestive heart failure patients aged 63 to 85 years with subclinical renal disease.
    Obialo CI; Ofili EO; Mirza T
    Am J Cardiol; 2002 Sep; 90(6):663-5. PubMed ID: 12231103
    [No Abstract]   [Full Text] [Related]  

  • 66. Safety of spironolactone use in ambulatory heart failure patients.
    Kandula P; Shah R
    Clin Cardiol; 2009 Jun; 32(6):347-8. PubMed ID: 19569078
    [No Abstract]   [Full Text] [Related]  

  • 67. Rationale and design of ARTS: a randomized, double-blind study of BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease.
    Pitt B; Filippatos G; Gheorghiade M; Kober L; Krum H; Ponikowski P; Nowack C; Kolkhof P; Kim SY; Zannad F
    Eur J Heart Fail; 2012 Jun; 14(6):668-75. PubMed ID: 22562554
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Eplerenone: new drug. Recent myocardial infarction with heart failure: a spironolactone me too.
    Prescrire Int; 2006 Apr; 15(82):46-9. PubMed ID: 16604728
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Selective aldosterone blocking in heart failure. Eplerenone reduces the risk after infarction].
    MMW Fortschr Med; 2003 Oct; 145(44):42-3. PubMed ID: 14655506
    [No Abstract]   [Full Text] [Related]  

  • 70. A pilot study of the effect of spironolactone therapy on exercise capacity and endothelial dysfunction in pulmonary arterial hypertension: study protocol for a randomized controlled trial.
    Elinoff JM; Rame JE; Forfia PR; Hall MK; Sun J; Gharib AM; Abd-Elmoniem K; Graninger G; Harper B; Danner RL; Solomon MA
    Trials; 2013 Apr; 14():91. PubMed ID: 23547564
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Safety of low-dose spironolactone administration in chronic haemodialysis patients.
    Saudan P; Mach F; Perneger T; Schnetzler B; Stoermann C; Fumeaux Z; Rossier M; Martin PY
    Nephrol Dial Transplant; 2003 Nov; 18(11):2359-63. PubMed ID: 14551366
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of aldosterone antagonism on myocardial dysfunction in hypertensive patients with diastolic heart failure.
    Mottram PM; Haluska B; Leano R; Cowley D; Stowasser M; Marwick TH
    Circulation; 2004 Aug; 110(5):558-65. PubMed ID: 15277317
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of spironolactone on left ventricular systolic and diastolic function in patients with early stage chronic kidney disease.
    Edwards NC; Ferro CJ; Kirkwood H; Chue CD; Young AA; Stewart PM; Steeds RP; Townend JN
    Am J Cardiol; 2010 Nov; 106(10):1505-11. PubMed ID: 21059444
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effects of aldosterone blockade on left ventricular function and clinical status during acute myocardial infarction.
    Uzunhasan I; Yildiz A; Coskun U; Kalyoncuoglu M; Baskurt M; Cakar MA; Kaya A; Pehlivanoglu S; Enar R; Okcun B
    Scand J Clin Lab Invest; 2009; 69(5):545-9. PubMed ID: 19347740
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Spironolactone treatment and clinical outcomes in patients with systolic dysfunction and mild heart failure symptoms: a retrospective analysis.
    Baliga RR; Ranganna P; Pitt B; Koelling TM
    J Card Fail; 2006 May; 12(4):250-6. PubMed ID: 16679256
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Spot urine sodium excretion as prognostic marker in acutely decompensated heart failure: the spironolactone effect.
    Ferreira JP; Girerd N; Medeiros PB; Santos M; Carvalho HC; Bettencourt P; Kénizou D; Butler J; Zannad F; Rossignol P
    Clin Res Cardiol; 2016 Jun; 105(6):489-507. PubMed ID: 26615605
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Long-term effects of spironolactone in peritoneal dialysis patients.
    Ito Y; Mizuno M; Suzuki Y; Tamai H; Hiramatsu T; Ohashi H; Ito I; Kasuga H; Horie M; Maruyama S; Yuzawa Y; Matsubara T; Matsuo S;
    J Am Soc Nephrol; 2014 May; 25(5):1094-102. PubMed ID: 24335969
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Effect of spironolactone in patients with heart failure and preserved left ventricular function - TOPCAT study].
    Widimský J
    Vnitr Lek; 2015 May; 61(5):376-80. PubMed ID: 26075843
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The adequacy of laboratory monitoring in patients treated with spironolactone for congestive heart failure.
    Shah KB; Rao K; Sawyer R; Gottlieb SS
    J Am Coll Cardiol; 2005 Sep; 46(5):845-9. PubMed ID: 16139135
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Influence of baseline and worsening renal function on efficacy of spironolactone in patients With severe heart failure: insights from RALES (Randomized Aldactone Evaluation Study).
    Vardeny O; Wu DH; Desai A; Rossignol P; Zannad F; Pitt B; Solomon SD;
    J Am Coll Cardiol; 2012 Nov; 60(20):2082-9. PubMed ID: 23083787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.